INC Research Holdings

INC Research is a leading, global full-service clinical research organization (CRO) providing the full range of Phase I to IV clinical development services for the world's pharmaceutical, biotech and medical device industries. As a therapeutically focused CRO, with a Trusted Process delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, investigative sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked "Top CRO to Work With" by sites worldwide in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.

Type
Public
HQ
Raleigh, US
Founded
1998
Size (employees)
6,800 (est)+7%
INC Research Holdings was founded in 1998 and is headquartered in Raleigh, US

INC Research Holdings Office Locations

INC Research Holdings has an office in Raleigh
Raleigh, US (HQ)
600 3201 Beechleaf Ct

INC Research Holdings Metrics

INC Research Holdings Financial Metrics

Revenue (2016)

$1.6 b

Revenue growth (2015-16), %

15%

Net income (2016)

$112.6 m

Market capitalization (21-Mar-2017)

$2.4 b

Closing share price (21-Mar-2017)

$44.3

Cash (31-Dec-2016)

$102.5 m
INC Research Holdings's current market capitalization is $2.4 b.
INC Research Holdings's revenue was reported to be $1.6 b in FY, 2016 which is a 15.1% increase from the previous period.
FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$1.2 b$1.4 b$1.6 b

Revenue growth, %

19%15%

Operating expense total

$1.1 b$1.2 b$1.5 b

EBIT

$63.6 m$152.4 m$155.4 m

EBIT margin, %

5%11%10%

Interest expense

$62.2 m$60.8 m($53 m)($15.6 m)($12 m)

Interest income

$249 k$192 k$216 k

Pre tax profit

($28.2 m)

Income tax expense

($35.7 m)$10.8 m$4.7 m($13.9 m)($21.5 m)

Net Income

($23.5 m)$117 m$112.6 m
Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016

Cash

$71 m$81.4 m$97 m$126.5 m$85 m$102.5 m

Accounts Receivable

$6.2 m$6.6 m

Inventories

$441 k$315 k

Current Assets

$426.9 m$422 m$522.6 m

PP&E

$43.7 m$44.8 m$58.3 m

Goodwill

$556.9 m$553 m$552.5 m

Total Assets

$1.2 b$1.2 b$1.3 b

Current Liabilities

$379.8 m$474.6 m$466.7 m

Additional Paid-in Capital

$634.9 m$559.9 m$573.2 m

Retained Earnings

($217.1 m)($301.5 m)($230 m)

Total Equity

$392.2 m$217.4 m$301.5 m

Financial Leverage

3.2 x5.6 x4.3 x
FY, 2014FY, 2015FY, 2016

Net Income

($23.5 m)$117 m$112.6 m

Depreciation and Amortization

$54.5 m$56 m$59.2 m

Accounts Receivable

($2.7 m)($5.6 m)($8.9 m)

Inventories

$3.4 m$1.1 m$2.6 m

Cash From Operating Activities

$29.5 m($41.4 m)$109.3 m

Purchases of PP&E

($25.6 m)($21.1 m)($31.4 m)

Cash From Investing Activities

($27.9 m)($21.1 m)($31.4 m)

Long-term Borrowings

($164.1 m)($475 m)

Dividends Paid

($375 k)

Cash From Financing Activities

($67.7 m)($211.4 m)($53.3 m)

Interest Paid

$64.3 m$17.5 m$11.6 m

Income Taxes Paid

$6.3 m$8.3 m$24.3 m

INC Research Holdings Market Value History

INC Research Holdings Online Presence

INC Research Holdings Company Life

You may also be interested in